S L Nightingale1. Show Affiliations » 1. Office of Health Affairs, FDA, Rockville, MD 20857, USA.
Abstract
Mesh: See more » AbciximabAcquired Immunodeficiency Syndrome/drug therapyAngioplasty/adverse effectsAngioplasty/methodsAntibodies, Monoclonal/therapeutic useAntimetabolites, Antineoplastic/therapeutic useDeoxycytidine/analogs & derivativesDeoxycytidine/therapeutic useDrugs, Investigational/therapeutic useGrowth Hormone/therapeutic useHumansImmunoglobulin Fab Fragments/therapeutic useNonprescription Drugs/standardsPancreatic Neoplasms/drug therapyPlatelet Aggregation Inhibitors/therapeutic useRecombinant Proteins/therapeutic useSpermatocidal Agents/standardsUnited StatesUnited States Food and Drug Administration
Substances: See more » Antibodies, MonoclonalAntimetabolites, AntineoplasticDrugs, InvestigationalImmunoglobulin Fab FragmentsNonprescription DrugsPlatelet Aggregation InhibitorsRecombinant ProteinsSpermatocidal AgentsDeoxycytidineGrowth HormonegemcitabineAbciximab
Year: 1995 PMID: 7897804 DOI: 10.1001/jama.273.13.982
Source DB: PubMed Journal: JAMA ISSN: 0098-7484 Impact factor: 56.272